article · Research Journal of Applied Biotechnology
With the aid of hydrazone moiety, a novel Cd(II) chelate with 2-[(4-methylphenyl)amino]-N'-[(Z)-thiophen-2-ylmethylidene]acetohydrazide (H2L) was created and reported. These novel chemicals' structural makeup was clarified through the utilization of spectroscopic and analytical methods. The chelates were molded with a molar ratio of 1:1 M:L and the formula [Cd(H2L)Cl2]. Cd(II) complex of the biological activity ligand is investigated. Theoretical measurements supported the proposed generic formula for the [Cd(H2L)Cl2] complex. The compound's anticancer and antibacterial properties were evaluated using cisplatin, gentamicin, and ampicillin as standards. It was found that the Cd 2+ complex was more effective against two cancer cell lines and several bacterial strains than it was against ligand. The results showed that the compound's activities were: Cd(II) complex > H2L, with Cd(II) complex exhibiting the maximum activity. By examining the binding between the complex and Penicillin-binding protein PBP, which is primarily thought of as the production of the cell wall through its transglycosylation and transpeptidation, a molecular docking study was carried out to support the microbial inhibition growth.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/rjab.2024.312873.1055
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.